1. Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein
   Maike Sieben et al, 2008, World Journal of Gastroenterology CrossRef
2. Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene
   Matthew Marr et al, 2018, Viruses CrossRef
3. Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
   Assia L. Angelova et al, 2009, Clinical Cancer Research CrossRef
4. Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
   Assia Angelova et al, 2017, Viruses CrossRef
5. Assessment of the Efficient Strategies for Applying Antitumor Viral Vaccine Therapy Based On Mathematical Modeling
   N.A. Babushkina et al, 2019, Mathematical Biology and Bioinformatics CrossRef
6. Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer
   Assia L. Angelova et al, 2014, Journal of Virology CrossRef
7. Immune System Stimulation by Oncolytic Rodent Protoparvoviruses
   Assia Angelova et al, 2019, Viruses CrossRef
8. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
   Antonio Marchini et al, 2019, Frontiers in Immunology CrossRef